Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $29.75 | Total: $148.75 |
| 1 | 10 | $25.20 | Total: $252.00 |
| 1 | 25 | $21.35 | Total: $533.75 |
| 1 | 50 | $18.20 | Total: $910.00 |
| 1 | 100 | $15.75 | Total: $1,575.00 |
Overview
ERK5-IN-2 is an orally active, sub-micromolar, selective ERK5 inhibitor with IC50 values of 0.82 ?M for ERK5 and 3 ?M for ERK5 (MEF2D).
Chemical Properties
| Molecular Formula | C17H11BrFN3O2 |
| Molecular Weight | 388.19 |
| CAS Numbers | 1888305-96-1 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | Fc1cccc(Br)c1C(=O)c1c[nH]c(c1)C(=O)Nc1cccnc1 |
Storage and Handling
0C Short Term, -20C Long Term
References
Myers SM, Miller DC, Molyneux L, et al .Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38? and BRD4[J].Eur J Med Chem. 2019 Sep 15;178 530-543.